TrialPloS one2015

Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial.

Katherine A Sutherland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.